Prevalence of cardiovascular manifestations in Marfan syndrome;Prevalenza delle manifestazioni cardiovascolari nella sindrome di Marfan

Italian Heart Journal, Supplementi

Volumn 5, Issue 8, 2004, Pages 647-652

  Porciani, Maria Cristina ^a   Attanasio, Monica ^a   Lepri, Valentina ^a   Lapini, Ilaria ^a   Demarchi, Gabriele ^a   Padeletti, Luigi ^a   Pepe, Guglielmina ^a   Abbate, Rosanna ^a   Gensini, Gian Franco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Aorta; Marfan syndrome; Mitral valve prolapse

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; MALE; MARFAN SYNDROME; PREVALENCE;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MARFAN SYNDROME; PREVALENCE;

EID: 21644469675     PISSN: 15903796     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pyeritz RE.The Marfan syndrome. Annu Rev Med 2000; 51: 481-510.
2. Dietz HC, Pyretz RE. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet 1995; 4: 1799-809.
3. Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 1986; 103: 2499-509. (Pubitemid 17216674)
4. Murdoch JI, Walker BA Halpern BL, Kuzma JW, McKusick VA. Life expectancy and causes of death in the Marfan syndrome. N Engl J Med 1972; 286: 804-8.
5. Silverman DI, Burton KJ, Gray J, et al. Life expectancy in the Marfan syndrome. Am J Cardiol 1995; 75: 157-60.
6. De Paepe A, Devereux RB, Dietz HC, Hennekam RCM, Pyretz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62: 417-26. (Pubitemid 26131122)
7. Playford D, Weyman AE. Mitral valve prolapse: time for a fresh look. Rev Cardiovasc Med 2001; 2: 73-81.
8. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987; 75: 175-83. (Pubitemid 17234556)
9. Miyatake K, Okamoto M, Kinoshita N, et al. Semi-quantitative grading of severity of mitral regurgitation by real-time two-dimensional Doppler flow imaging technique. J Am Coll Cardiol 1986; 7: 82-8.
10. Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J. Two- dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 1989; 64: 507-12. (Pubitemid 19214582)
11. Feigenbaum H. Current status of M-mode echocardiography. (abstr) ACC Current Journal Review 1994; 3: 58.
12. Van Karnebeek CD, Naeff MS, Mulder BJ, Hennekam RC, Offringa M. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child 2001; 84: 129-37. (Pubitemid 32150328)
13. Yetman AT, Huang P, Bornemeier RA, McCrindle BW. Comparison of outcome of the Marfan syndrome in patients diagnosed at age < or = 6 years versus those diagnosed at > 6 years of age. Am J Cardiol 2003; 91: 1228-35.
14. Recchia D, Sharkey AM, Bosner MS, Kouchoukos NT, Wckline SA. Sensitive detection of abnormal aortic architecture in Marfan syndrome with high-frequency ultrasonic tissue characterization. Circulation 1995; 91: 1036-43.
15. Lopes LM, Cha SC, de Moraes EA, Zugaib M. Echocardiographic diagnosis of fetal Marfan syndrome at 34 weeks' gestation. Prenat Diagn 1995; 15: 183-5.
16. Perloff JK, Roberts WC. The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation 1972; 46: 227-39.
17. Chatrath R, Beauchesne M, Connolly M, Michels VV, Driscoll DJ. Left ventricular function in the Marfan syndrome without significant valvular regurgitation. Am J Cardiol 2003; 91: 914-6. (Pubitemid 36363751)
18. Savolanein A, Nisula L, Keto P, Viitasalo M, Kaitilia I, Kupari M. Left ventricular function in children with the Marfan syndrome. Eur Heart J 1994; 15: 625-30. (Pubitemid 24186328)
19. Porciani MC, Giurlani L, Chelucci A, et al. Diastolic subclinical primary alterations in Marfan syndrome and Marfan-related disorders. Clin Cardiol 2002; 25: 416-20. (Pubitemid 34983315)
20. Nataatmadja M, West M, West J, et al. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation 2003; 108 (Suppl 1): II329-II334. (Pubitemid 37099977)
21. Yetman AT, Bornemeier RA, McCrindle BW. Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? J Am Coll Cardiol 2003; 41: 329-32.
22. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 1994; 330: 1335-41.
23. Immer FF, Bansi AG, Immer-Bansi AS, et al. Aortic dissection in pregnancy: analysis of risk factors and outcome. Ann Thorac Surg 2003; 76: 309-14.
24. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus non surgical risks. Ann Thorac Surg 2002; 74: S1877-S1880.
25. Januzzi JL, Isselbacher EM, Fattori R, et al. Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol 2004; 43: 665-9. (Pubitemid 38229542)
26. Gelsomino S, Fasullo G, Morocutti G, et al. Sixteen-year results of composite aortic root replacement for non-dissecting chronic aortic aneurysms. Ital Heart J 2003; 4: 454-9.